Atıf Formatları
Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel resistant prostate cancer cells PC 3 R and DU 145 R
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Z. G. SÜRMELİ Et Al. , "Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel resistant prostate cancer cells PC 3 R and DU 145 R," 2014 ASCO Annual Meeting , 2014

SÜRMELİ, Z. G. Et Al. 2014. Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel resistant prostate cancer cells PC 3 R and DU 145 R. 2014 ASCO Annual Meeting .

SÜRMELİ, Z. G., bozkurt, e., özer, ö., ATMACA, H., kısım, a., UZUNOĞLU, S., ... USLU, F. R.(2014). Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel resistant prostate cancer cells PC 3 R and DU 145 R . 2014 ASCO Annual Meeting

SÜRMELİ, ZEKİ Et Al. "Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel resistant prostate cancer cells PC 3 R and DU 145 R," 2014 ASCO Annual Meeting, 2014

SÜRMELİ, ZEKİ G. Et Al. "Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel resistant prostate cancer cells PC 3 R and DU 145 R." 2014 ASCO Annual Meeting , 2014

SÜRMELİ, Z. G. Et Al. (2014) . "Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel resistant prostate cancer cells PC 3 R and DU 145 R." 2014 ASCO Annual Meeting .

@conferencepaper{conferencepaper, author={ZEKİ GÖKHAN SÜRMELİ Et Al. }, title={Enhancement of docetaxel efficacy by zoledronic acid pretreatment in docetaxel resistant prostate cancer cells PC 3 R and DU 145 R}, congress name={2014 ASCO Annual Meeting}, city={}, country={}, year={2014}}